KRAS-IRF2 Axis Drives Immune Suppression and Immune Therapy Resistance in Colorectal Cancer
The University of Texas MD Anderson Cancer Center · Key Laboratory of Guangdong Province · +5 more institutions
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
603
total citations
- FWCI
- 27.97
- Percentile
- 100%
- References
- 65
Citations per year
Authors
27- WLWenting Liao
The University of Texas MD Anderson Cancer Center, Key Laboratory of Guangdong Province, Nanfang Hospital, Guangzhou Medical University Cancer Hospital, Southern Medical University, Guangzhou Medical University
- MJMichael J. Overman
The University of Texas MD Anderson Cancer Center
- ATAdam T. Boutin
The University of Texas MD Anderson Cancer Center
- XSXiaoying Shang
The University of Texas MD Anderson Cancer Center
- DZDi Zhao
The University of Texas MD Anderson Cancer Center
Topics & keywords
Topics
Keywords
- Immune system
- KRAS
- Colorectal cancer
- Cancer research
- Medicine
- Cancer
- Immunology
- Oncology
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.
Funding
- CPCancer Prevention and Research Institute of TexasAward: RP170067
- NNNational Natural Science Foundation of ChinaAwards: 81672886, 81872401, 81773101
- NINational Institutes of HealthAwards: R01 CA084628, PO1 CA117969
- UOUniversity of Texas MD Anderson Cancer Center
- NKNational Key Research and Development Program of ChinaAward: 2015CB554002